Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-08 Option Award | 2024-02-12 4:05 pm | N/A 2034-02-07 | Astria Therapeutics Inc. | ATXS | Harshbarger Benjamin Chief Legal Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 08:07 am | N/A 2033-01-31 | Astria Therapeutics Inc. | ATXS | Harshbarger Benjamin Chief Legal Officer | 90,000 | $0 | 90,000 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 7:21 pm | N/A N/A | Astria Therapeutics Inc. | ATXS | Harshbarger Benjamin Chief Legal Officer | 55,000 | $0 | 55,000 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-10 4:06 pm | N/A 2031-06-07 | CATABASIS PHARMACEUTICALS INC | CATB | Harshbarger Benjamin Chief Legal Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-02 7:13 pm | N/A 2031-03-31 | CATABASIS PHARMACEUTICALS INC | CATB | Harshbarger Benjamin Senior VP, General Counsel | 400,000 | $0 | 400,000 (Direct) | View |
| 2020-06-11 Option Award | 2020-06-12 11:47 am | N/A 2030-06-10 | CATABASIS PHARMACEUTICALS INC | CATB | Harshbarger Benjamin Secretary and General Counsel | 45,000 | $0 | 45,000 (Direct) | View |
| 2019-05-09 Tax Withholding | 2019-05-13 4:05 pm | N/A N/A | NOVELION THERAPEUTICS INC. | NVLN | Harshbarger Benjamin See Remarks | 212 | $1.22 | 3,683 (Direct) | View |